Literature DB >> 3548099

[Glucagon, its discovery and description and the work of Max Bürger].

K Seige.   

Abstract

After intravenous injection of technical insulin (lower degree of purity) already in 1923 Murlin observed transient initial increases of blood sugar. He suggested that this would be caused by another hormone and he gave him the name of glucagon. Nearly from 1928 Bürger dealt with the synergistic effect of muscle work and intravenous application of insulin on the blood sugar. Here he also established the blood sugar increasing principle glucagon. Subsequently by animal experimental and clinical examinations he essentially contributed to the characterization of the substance itself and its mode of action. He always acknowledged the priority of Murlin. The statement of the A-cells of the pancreas as the place of the synthesis of glucagon, the clarification of its structure and its pure preparation caused the fact that nowadays comprehensive knowledge about the second pancreatic hormone is available.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3548099

Source DB:  PubMed          Journal:  Z Gesamte Inn Med        ISSN: 0044-2542


  1 in total

Review 1.  Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives.

Authors:  Dimitris Kounatidis; Natalia G Vallianou; Dimitrios Tsilingiris; Gerasimos Socrates Christodoulatos; Eleni Geladari; Theodora Stratigou; Irene Karampela; Maria Dalamaga
Journal:  Curr Nutr Rep       Date:  2022-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.